Global Creatinine Measurement 2018-2023: Commercialization of Advanced Testing Methods Presents Market Opportunities
DUBLIN, June 15, 2018 /PRNewswire/ --
The "Creatinine Measurement Market by Product, Test Type, Sample and End User , Region - Global Forecast to 2023" report has been added to ResearchAndMarkets.com's offering.
The global creatinine measurement market is expected to reach USD 564.5 Million by 2023 from USD 377.2 Million in 2018, at a CAGR of 8.4%.
The growth of this market is mainly driven by increasing incidence of renal disorders, growing incidence of other chronic disorders impacting renal function, rising awareness and adoption of preventive healthcare approaches, implementation of favorable government initiatives to promote renal health, rapid growth in the geriatric population, and increasing number of drug development initiatives.
This report segments the creatinine measurement market on the basis of type, type of sample, end user, product, and region. By type, the market is segmented into Jaffe's kinetic method and enzymatic method. In 2018, the Jaffe's kinetic method segment is estimated to account for the largest share of the creatinine measurement market, as it is the oldest and most conventional method for creatinine measurement in clinical samples. Additionally, the widespread availability and cost-effectiveness of kits and reagents used in Jaffe's kinetic method is another major factor responsible for the large share of this segment.
Based on type of sample, the market is segmented into blood/serum and urine samples. The blood sample segment accounted for the largest share of the creatinine measurement market in 2017 due to the increased accuracy and low risk of contamination. This segment is also expected to witness the highest growth over the forecast period, as it is the most preferred sample type for accurate measurement of creatinine levels.
Based on end user, the creatinine measurement market is segmented into hospitals and diagnostic laboratories. In 2018, the hospitals segment is expected to account for the largest share of the creatinine measurement owing to established infrastructures with an advanced diagnostic assembly for better diagnostic results within shorter time spans. The diagnostic laboratories segment is expected to witness the highest growth over the forecast period as various market players are entering into long-term collaborations with diagnostic laboratories in order to increase their presence in the creatinine measurement market.
In 2017, North America dominated the market followed by Europe. Asia is expected to grow at the highest CAGR during the forecast period. This can be attributed to factors such as the growing prevalence of CKD, rising awareness about preventive healthcare, improving healthcare infrastructure, and growing focus of market players on addressing the demands in several Asian countries. Also, as developed markets are reaching saturation levels, Asia is expected to become a hotspot for creatinine kits and reagents providers However, identification of novel renal dysfunction biomarkers and frequently changing regulatory policies are expected to challenge market growth in the coming years.
Key Topics Covered:
1 Introduction
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
5.1 Introduction
5.2 Market Drivers
5.2.1 Increasing Incidence of Renal Disorders
5.2.2 Growing Incidence of Other Chronic Disorders Impacting Renal Function
5.2.3 Growing Awareness and Adoption of Preventive Healthcare
5.2.4 Favorable Government Initiatives to Promote Renal Health
5.2.5 Rapid Growth in the Geriatric Population
5.2.6 Increasing Number of Drug Development Initiatives
5.3 Market Restraints/Challenges
5.3.1 Identification of Novel Renal Dysfunction Biomarkers
5.3.2 Frequently Changing Regulatory Policies
5.4 Market Opportunities
5.4.1 High Growth Potential in Emerging Economies
5.4.2 Commercialization of Advanced Testing Methods
6 Creatinine Test Kits and Reagents Market, By Product
6.1 Introduction
6.2 Reagents
6.3 Kits
7 Creatinine Test Kits and Reagents Market, By Type
7.1 Introduction
7.2 Jaffe's Kinetic Method
7.3 Enzymatic Method
8 Creatinine Test Kits and Reagents Market, By Sample Type
8.1 Introduction
8.2 Blood/Serum
8.3 Urine
9 Creatinine Test Kits and Reagents Market, By End User
9.1 Introduction
9.2 Hospitals
9.3 Diagnostic Laboratories
10 Creatinine Test Kits and Reagents Market, By Region
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Rest of the Europe
10.4 Asia
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Indonesia
10.4.5 Rest of the Asia
10.5 Rest of the World
10.5.1 Brazil
10.5.2 Other RoW Countries
11 Competitive Landscape
11.1 Creatinine Test Kits and Reagents Market: Competitive Intelligence (2017)
11.2 Creatinine Test Kits and Reagents Market: Market Share Analysis (2017)
11.3 Creatinine Test Kits and Reagents Market: Competetive Situation & Trends
12 Company Profiles
12.1 Introduction
12.2 Siemens Healthineers (A Division of Siemens AG)
12.3 F. Hoffmann-La Roche Ltd.
12.4 Abbott Laboratories
12.5 Danaher Corporation (Beckman Coulter)
12.6 Thermo Fisher Scientific Inc.
12.7 Randox Laboratories
12.8 Wako Pure Chemical Industries, Ltd
12.9 Pointe Scientific, Inc (A Part of Medtest Holdings)
12.10 Shenzhen Mindray Bio-Medical Electronics Co., Ltd
12.11 Ortho Clinical Diagnostics
12.12 Diazyme Laboratories, Inc
12.13 Dialab GmbH
12.14 Sentinel Ch. SPA
12.15 Diasys Diagnostic Systems GmbH
For more information about this report visit https://www.researchandmarkets.com/research/j9d7rw/global_creatinine?w=5
Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article